申请人:Cassin Mara
公开号:US20080261980A1
公开(公告)日:2008-10-23
The invention relates to the use of compounds of general formula (I), in which R
1
, R
2
and X are as defined in the description for the preparation of pharmaceutical compositions for the treatment of pathologies in which inhibition of the interaction between HIF-1α and p300 is beneficial, in particular as antiangiogenic medicaments for the therapy of solid tumors.
本发明涉及使用通式(I)中的化合物,其中R1、R2和X如说明书中所定义,用于制备药物组合物,用于治疗抑制HIF-1α和p300之间相互作用有益的病理情况,特别是作为治疗实体瘤的抗血管生成药物。